Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review

被引:4
作者
Rao, Karthik Nagaraja [1 ]
Randolph, Gregory W. [2 ]
Lopez, Fernando [3 ]
Zafereo, Mark [4 ]
Coca-Pelaz, Andres [3 ]
Piazza, Cesare [5 ]
Dange, Prajwal [1 ]
Rodrigo, Juan Pablo [3 ]
Stenman, Goeran [6 ]
de Keizer, Bart [7 ]
Nixon, Iain [8 ]
Sinha, Shriyash [1 ]
Leboulleux, Sophie [9 ]
Maekitie, Antti A. [10 ,11 ]
Agaimy, Abbas [12 ,13 ]
Thompson, Lester [14 ]
Ferlito, Alfio [15 ]
机构
[1] Sri Shankara Canc Hosp & Res Ctr, Dept Head & Neck Surg Oncol, Bangalore 560004, Karnataka, India
[2] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol Head & Neck Surg, Div Thyroid & Parathyroid Endocrine Surg, Boston, MA USA
[3] Univ Oviedo, Hosp Univ Cent Asturias, Dept Otolaryngol, CIBERONC,ISPA,IUOPA, Oviedo 33011, Spain
[4] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX USA
[5] ASST Spedali Civili Brescia, Unit Otorhinolaryngol Head & Neck Surg, Brescia, Italy
[6] Univ Gothenburg, Sahlgrenska Ctr Canc Res, Dept Pathol, Gothenburg, Sweden
[7] Univ Med Ctr Utrecht, Dept Nucl Med & Radiol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[8] Univ Edinburgh, Dept Surg & Otolaryngol Head & Neck Surg, Edinburgh EH3 9YL, Scotland
[9] Univ Geneva, Geneva Univ Hosp, Dept Endocrinol Diabetol Nutr & Therapeut Educ, Rue Gabrielle Perret Gentil, Geneva, Switzerland
[10] Univ Helsinki, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland
[11] Univ Helsinki, Res Program Syst Oncol, Helsinki, Finland
[12] Friedrich Alexander Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, D-91054 Erlangen, Germany
[13] Comprehens Canc Ctr Erlangen EMN CCC ER EMN, D-91054 Erlangen, Germany
[14] Head & Neck Pathol Consultat, Woodland Hills, CA 91364 USA
[15] Coordinator Int Head & Neck Sci Grp, Padua, Italy
关键词
Thyroid neoplasms; Risk assessment; Molecular testing; Bethesda system; Artificial intelligence; PERFORMANCE; PREDICTOR; CANCER;
D O I
10.1007/s12020-024-03737-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increasing prevalence of thyroid cancer emphasizes the need for a thorough assessment of risk of malignancy in Bethesda III nodules. Various methods ranging commercial platforms of molecular genetic testing (including Afirma (R) GEC, Afirma (R) GSC, ThyroSeq (R) V3, RosettaGX (R), ThyGeNEXT (R)/ThyraMIR (R), ThyroidPRINT (R)) to radionuclide scans and ultrasonography have been investigated to provide a more nuanced comprehension of risk estimation. The integration of molecular studies and imaging techniques into clinical practice may provide clinicians with improved and personalized risk assessment. This integrated approach we feel may enable clinicians to carefully tailor interventions, thereby minimizing the likelihood of unnecessary thyroid surgeries and overall crafting the optimal treatment. By aligning with the evolving landscape of personalized healthcare, this comprehensive strategy ensures a patient-centric approach to thyroid nodule and thyroid cancer management.
引用
收藏
页码:473 / 492
页数:20
相关论文
共 76 条
  • [31] Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort
    Guan, Haixia
    Toraldo, Gianluca
    Cerda, Sandra
    Godley, Frederick A.
    Rao, Sowmya R.
    McAneny, David
    Doherty, Gerard
    Braverman, Lewis
    Lee, Stephanie L.
    [J]. THYROID, 2020, 30 (04) : 536 - 547
  • [32] 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
    Haugen, Bryan R.
    Alexander, Erik K.
    Bible, Keith C.
    Doherty, Gerard M.
    Mandel, Susan J.
    Nikiforov, Yuri E.
    Pacini, Furio
    Randolph, Gregory W.
    Sawka, Anna M.
    Schlumberger, Martin
    Schuff, Kathryn G.
    Sherman, Steven I.
    Sosa, Julie Ann
    Steward, David L.
    Tuttle, R. Michael
    Wartofsky, Leonard
    [J]. THYROID, 2016, 26 (01) : 1 - 133
  • [33] Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine-needle aspiration
    Jin, Xiaobing
    Lew, Madelyn
    Pantanowitz, Liron
    Iyengar, Jennifer J.
    Haymart, Megan R.
    Papaleontiou, Maria
    Broome, David
    Sandouk, Zahrae
    Raja, Sobia S.
    Hughes, David T.
    Smola, Brian
    Jing, Xin
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (11) : 698 - 704
  • [34] BRAFV600E mutation as a predictor of thyroid malignancy in indeterminate nodules: A systematic review and meta-analysis
    Jinih, M.
    Foley, N.
    Osho, O.
    Houlihan, L.
    Toor, A. A.
    Khan, J. Z.
    Achakzai, A. A.
    Redmond, H. P.
    [J]. EJSO, 2017, 43 (07): : 1219 - 1227
  • [35] Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis
    Kaliszewski, Krzysztof
    Diakowska, Dorota
    Rzeszutko, Marta
    Nowak, Lukasz
    Wojtczak, Beata
    Sutkowski, Krzysztof
    Ludwig, Maksymilian
    Ludwig, Bartlomiej
    Greniuk, Maria
    Tokarczyk, Urszula
    Rudnicki, Jerzy
    [J]. BIOMEDICINES, 2022, 10 (08)
  • [36] Thyroid Nodule Molecular Testing: Is It Ready for Prime Time?
    Khan, Tahsin M.
    Zeiger, Martha A.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [37] Diagnostic Performance of Six Ultrasound Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Network Meta-Analysis
    Kim, Do Hyun
    Kim, Sung Won
    Basurrah, Mohammed Abdullah
    Lee, Jueun
    Hwang, Se Hwan
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2023, 220 (06) : 791 - 803
  • [38] Koster E.J., 2023, THYROID J AM THYROID
  • [39] Ultrasound characterization for thyroid nodules with indeterminate cytology: inter-observer agreement and impact of combining pattern-based and scoring-based classifications in risk stratification
    Lam, Cesar A.
    McGettigan, Melissa J.
    Thompson, Zachary J.
    Khazai, Laila
    Chung, Christine H.
    Centeno, Barbara A.
    McIver, Bryan
    Valderrabano, Pablo
    [J]. ENDOCRINE, 2019, 66 (02) : 278 - 287
  • [40] Diagnostic value and challenges of BRAF V600E molecular testing and thyroid FNA cytology: a retrospective study from a tertiary institution in southern Hunan Province, China
    Lan, Zhihua
    Yang, Fang
    Zhang, Jing
    Lan, Ya
    Li, Hongtao
    He, Rongfang
    [J]. ACTA CYTOLOGICA, 2023, 67 (06) : 629 - 638